Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Colleen’s Dream Foundation Grants $11,000 to Memorial Sloan-Kettering Cancer Center to Fund Ovarian Cancer Research
  • USA - English


News provided by

Colleen's Dream Foundation

Feb 19, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Vance Broach, a Gynecologic Oncology Fellow at Memorial Sloan-Kettering Cancer Center
Dr. Vance Broach, a Gynecologic Oncology Fellow at Memorial Sloan-Kettering Cancer Center

Phoenix, AZ (PRWEB) February 19, 2014 -- With the help of ovarian cancer survivor Jill Pall and NFL kicker Ryan Quigley, Colleen’s Dream Foundation has granted $11,000, to Memorial Sloan-Kettering Cancer Center to help fund ovarian cancer research being conducted by Dr. Vance Broach, according to Colleen’s Dream Foundation President Billy Cundiff.

“We are excited to fund the research being conducted by Dr. Broach,” says Cundiff. “His work is both cutting edge, and extremely important in making the early detection of ovarian cancer a reality.”

Cundiff says it's individuals like Pall and Quigley that help Kicking For The Dream support Colleen’s Dream Foundation efforts to fight ovarian cancer.

Post this

Broach, a Gynecologic Oncology Fellow at Memorial Sloan-Kettering Cancer Center, says his research focuses on using the molecular basis of ovarian cancer to find novel tests that allow for both the identification of ovarian cancer in its early stages and predict patients’ response to therapy.

“Specifically, we are studying microscopic particles called “exosomes” which are shed by cancer cells, and contain the molecular fingerprint of cells that originate in the ovary,” he says. “Our initial research has demonstrated that exosomes contain a genetic material called microRNA. Exosomes derived from ovarian cancer are unique from those derived from normal tissues in both the type and quantity of microRNA they contain. Exosomes are easily isolated from blood samples and therefore hold great promise as potential biomarkers.”

Broach says the potential results of this research could have important implications in detecting, and treating, ovarian cancer.

“We predict ovarian cancer derived exosomes will serve as a sensitive surrogate for the presence of tumor cells and will allow us both to detect ovarian cancers earlier and to offer more effective and timely therapy to our patients,” he says.

Cundiff says the $11,000 grant money given to Memorial Sloan-Kettering Cancer Center was raised by cancer survivor Jill Pall and NFL kicker Ryan Quigley through Kicking For The Dream, an online fundraising platform created by Cundiff to raise money for Colleen’s Dream Foundation.

Pall says she heard about Kicking For The Dream through social media and wanted to be part of it because of her own experience with ovarian cancer.

“I had presented to a gynecologist all of the symptoms of ovarian cancer but was told I was fine and my pain was normal,” says Pall. “In fact, the doctor told me to take over the counter pain medication and to come back in a year. Had I listened to her instead of going to the hospital, I probably would not have survived my cancer.”

It was after reading an abstract written by Dr. Broach, that Pall decided to dedicate her fundraising efforts towards his early detection research project at Memorial-Sloan Kettering Cancer Center.

Ryan Quigley, punter for the New York Jets, teamed up with Pall in the Kicking For The Dream fundraising effort for the Memorial Sloan-Kettering Cancer Center grant. He says raising money for this grant has raised his awareness about how deadly ovarian cancer is, and how important early detection research is.

“Since becoming a part of Kicking For The Dream, I have become aware of all the research and contributions that are being made to ovarian cancer,” says Quigley. “It is a blessing to be part of Kicking For The Dream to encourage, and support, continued research for this deadly disease.”

Cundiff says it's individuals like Pall and Quigley that help Kicking For The Dream support Colleen’s Dream Foundation efforts to fight ovarian cancer.

“We love what Jill Pall and Ryan Quigley have accomplished,” says Cundiff. “It's only fitting that all the money they raised stays close to home for them.”

Go here for more about Kicking For The Dream

ABOUT MEMORIAL SLOAN-KETTERING CANCER CENTER:

Memorial Sloan-Kettering Cancer Center — the world's oldest and largest private cancer center — has devoted more than 125 years to exceptional patient care, innovative research, and outstanding educational programs. Today, it is one of 41 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.

The close collaboration between MSKCC’s physicians and scientists is one of the Center’s unique strengths, enabling MSKCC to provide patients with the best care available while discovering more-effective strategies to prevent, control, and ultimately cure cancer in the future. Education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and biomedical research around the world.

ABOUT COLLEEN’S DREAM FOUNDATION:

Colleen’s Dream Foundation started in 2012 and supports research for early detection and improved treatment for ovarian cancer. The story of Colleen’s Dream started in 2007 when Colleen Drury –Nicole Cundiff’s mother and Billy Cundiff's mother-in-law- was diagnosed with late-stage ovarian cancer. The family became aware of a new world that was filled with invasive surgery, harsh chemotherapy, and lots of uncertainty, and realized they needed to help others who were dealing with ovarian cancer.

Colleen’s Dream Foundation believes it is important to raise money for research that will lead to reliable early detection testing and improved treatment for ovarian cancer. Because so little is known about ovarian cancer in proportion to other women’s health issues, there is an incredible opportunity for research and education.

Colleen's Dream Foundation is a qualified 501 (c)(3) tax exempt non-profit organization based in Phoenix, Arizona.

Admin, Colleen's Dream Foundation, +1 (480) 269-2266, [email protected]

Modal title

Colleen’s Dream Foundation President - and NFL Kicker - Billy Cundiff
Colleen’s Dream Foundation President - and NFL Kicker - Billy Cundiff
Ovarian Cancer Survivor Jill Pall
Ovarian Cancer Survivor Jill Pall
New York Jets Punter Ryan Quigley
New York Jets Punter Ryan Quigley
Colleen Drury - The Inspiration for Colleen's Dream Foundation and Kicking For The Dream
Colleen Drury - The Inspiration for Colleen's Dream Foundation and Kicking For The Dream
Colleen’s Dream Foundation President - and NFL Kicker - Billy Cundiff Ovarian Cancer Survivor Jill Pall New York Jets Punter Ryan Quigley Colleen Drury - The Inspiration for Colleen's Dream Foundation and Kicking For The Dream

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.